SG/CALL/MERCK/230/0.1/19.12.25 Share Price

Warrant

DE000SU9GP27

Market Closed - Boerse Frankfurt Warrants 20:40:29 24/05/2024 BST
0.74 EUR +2.78% Intraday chart for SG/CALL/MERCK/230/0.1/19.12.25
Current month+80.49%
1 month+60.87%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24/05/24 0.74 +2.78%
23/05/24 0.72 +5.88%
22/05/24 0.68 0.00%
21/05/24 0.68 +4.62%
20/05/24 0.65 -4.41%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 08:40 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SU9GP2
ISINDE000SU9GP27
Date issued 16/02/2024
Strike 230
Maturity 19/12/2025 (572 Days)
Parity 10 : 1
Emission price 0.68
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.75
Lowest since issue 0.38
Spread 0.02
Spread %2.63%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.8 EUR
Average target price
182.9 EUR
Spread / Average Target
+9.05%
Consensus